Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a newly recognized benign clinicopathological
entity. Arch Pathol....
Maia RC, Meis E, Romano S, et al. Rosai- Dorfman disease: a
report of eight cases in a tertiary care center and a review of
the literature....
Brenn T, Calonje E, Granter SR, et al. Cutaneous rosai-dorfman
disease is a distinct clinical entity. Am J Dermatopathol. 2002;24
(5):385–391....
Fang S, Chen AJ. Facial cutaneous Rosai-Dorfman disease: a
case report and literature review. Exp Ther Med. 2015;9(4):
1389–1392. https://doi.org/10.3892/etm.2015.2260.
De Pasquale R, Longo V, Pavone A, et al. Cutaneous RosaiDorfman disease. Giornale Italiano di Dermatologia e Venereologia:
Organo Ufficiale,...
Sun NZ, Galvin J, Cooper KD. Cutaneous Rosai-Dorfman
disease successfully treated with low-dose methotrexate.
JAMA Dermatol. 2014;150(7):787–788....
Conde JM, Kim AY, de Miguel R, et al. Enfermedad de RosaiDorfman cutánea: una nueva presentación clínica. Actas
Dermo-Sifiliograficas. 2018;109(7):655–657....
Rubenstein MA, Farnsworth NN, Pielop JA, et al. Cutaneous
rosai-dorfman disease. Dermatol Online J. 2006;12(1):8.
Emile JF, Abla O, Fraitag S, et al. Revised classification of
histiocytoses and neoplasms of the macrophage-dendritic cell
lineages. Blood....
Dalia S, Sagatys E, Sokol L, et al. Rosai-dorfman disease: tumor
biology, clinical features, pathology, and treatment. Cancer
Control J Moffitt...
Liu P, Wang P, Du J, et al. Successful treatment of refractory
cutaneous Rosai-Dorfman disease with vincristine. J Dermatol.
2015;42(1):97–98....
Utikal J, Ugurel S, Kurzen H, et al. Imatinib as a treatment
option for systemic non-Langerhans cell histiocytoses. Arch
Dermatol. 2007;143(6):736–740....
Conde JM, Kim AY, de Miguel R, et al. Enfermedad de rosaidorfman cutánea: una nueva presentación clínica. Actas
Dermo-Sifiliograficas. 2018;109(7):655–657....